Analysts think CDTX stock price could increase by 16%
Sep 08, 2025, 11:25 AM
61.71%
What does CDTX do
Cidara Therapeutics, a San Diego-based biotechnology company with 69 employees, focuses on developing targeted immunotherapies for serious diseases, including oncology and antiviral treatments. Its lead candidate, CBO421, targets solid tumors, while CD388 addresses influenza prevention and treatment.
8 analysts think CDTX stock price will increase by 16.25%. The current median analyst target is $73.44 compared to a current stock price of $63.17. The lowest analysts target is $45.45 and the highest analyst target is $120.75.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.